A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma

Published:2008 Issue:4 Volume:112 Page:856-862
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Zinzani Pier Luigi,Tani Monica,Fanti Stefano,Stefoni Vittorio,Musuraca Gerardo,Vitolo Umberto,Perrotti Alessio,Fina Mariapaola,Derenzini Enrico,Baccarani Michele

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference41 articles.

1. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori

2. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone.

3. Treatment of advanced non-Hodgkin's lymphomas with favorable histologies: preliminary results of a prospective trial

4. The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radioligand Therapy in Lymphoma;PET Clinics;2024-10

2. Radioimmunotherapy;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

3. Adverse events of radioimmunotherapy for non-Hodgkin lymphoma: A systematic review and meta-analysis;Leukemia Research;2021-09

4. How do we sequence therapy for marginal zone lymphomas?;Hematology;2020-12-04

5. Long-term outcomes of frontline 90Y-ibritumomab tiuxetan in marginal zone lymphoma;Leukemia & Lymphoma;2020-08-05